BioCentury
ARTICLE | Politics & Policy

China releases list of overseas drugs eligible for Priority Review

August 9, 2018 10:00 PM UTC

China’s Drug Evaluation Center posted a list of 48 drugs already approved in the U.S., EU or Japan that could be eligible for Priority Review in China.

Last December, China's State Drug Administration released guidance to implement a priority review pathway to accelerate the development and approval of new drugs with "significant clinical value" (see "CFDA Outlines Priority Review Pathway")...